Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Aminocarbonylation of 2-(N-substituted) 5-iodobenzoates: synthesis of glyoxylamido-anthranilates, their cytotoxicity and molecular modeling study. / Cheremnykh, Kirill P.; Baev, Dmitry S.; Nacharova, Elizaveta A. и др.
в: Chemical Papers, Том 78, № 9, 06.2024, стр. 5639-5656.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Aminocarbonylation of 2-(N-substituted) 5-iodobenzoates: synthesis of glyoxylamido-anthranilates, their cytotoxicity and molecular modeling study
AU - Cheremnykh, Kirill P.
AU - Baev, Dmitry S.
AU - Nacharova, Elizaveta A.
AU - Pokrovskii, Mikhail A.
AU - Savelyev, Victor A.
AU - Meshkova, Yulia V.
AU - Marenina, Mariya K.
AU - Tolstikova, Tatyana G.
AU - Pokrovskii, Andrey G.
AU - Shults, Elvira E.
N1 - This work was supported from the Russian Science Foundation, Grant Number: 23-73-00077.
PY - 2024/6
Y1 - 2024/6
N2 - The aminocarbonylation of ethyl 2-substituted 5-iodobenzoate has been investigated in the presence of a series of amine nucleophiles, providing an efficient synthetic route for producing various 5-carboxamide and 5-glyoxylamide derivatives of 2-(N-substituted) ethylbenzoates. It was shown, after detailed optimization study, that the formation of amides and α-ketoamides is strongly influenced by the reaction conditions. Performing the reactions of ethyl 2-substituted 5-iodobenzoate with nitrogen nucleophiles at 1 atm of carbon monoxide pressure in the presence of [Pd(η3-C3H5)(μ-Cl)]2 as a palladium source and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) as the base, the corresponding 2-ketocarboxamides were formed as major products (up to 60%). We have characterized the cytotoxicity (MTT test) and SAR of a new class of 2-(N-substituted) ethylbenzoate 5-amides and 5-(α-keto)amides. 5-Glyoxylamido derivatives 9a,b, 14a,d exhibited remarkably good cytotoxic potential on MCF-7 and T98G cancer cell lines. In addition, all the synthesized compounds were found to be non-toxic against normal cells (DF-2). The readily available nitrogen substituted 5-glyoxylamido-2-(N-acetylamino)ethylbenzoates 14a,d may serve as lead molecules for the future research regarding the identification of new anticancer agents. These novel compounds were confirmed to be cyclin-dependent kinase 6 and 9 (CDK6 and 9) inhibitors through in silico molecular modeling studies for the mode of action. Graphical abstract: (Figure presented.)
AB - The aminocarbonylation of ethyl 2-substituted 5-iodobenzoate has been investigated in the presence of a series of amine nucleophiles, providing an efficient synthetic route for producing various 5-carboxamide and 5-glyoxylamide derivatives of 2-(N-substituted) ethylbenzoates. It was shown, after detailed optimization study, that the formation of amides and α-ketoamides is strongly influenced by the reaction conditions. Performing the reactions of ethyl 2-substituted 5-iodobenzoate with nitrogen nucleophiles at 1 atm of carbon monoxide pressure in the presence of [Pd(η3-C3H5)(μ-Cl)]2 as a palladium source and DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) as the base, the corresponding 2-ketocarboxamides were formed as major products (up to 60%). We have characterized the cytotoxicity (MTT test) and SAR of a new class of 2-(N-substituted) ethylbenzoate 5-amides and 5-(α-keto)amides. 5-Glyoxylamido derivatives 9a,b, 14a,d exhibited remarkably good cytotoxic potential on MCF-7 and T98G cancer cell lines. In addition, all the synthesized compounds were found to be non-toxic against normal cells (DF-2). The readily available nitrogen substituted 5-glyoxylamido-2-(N-acetylamino)ethylbenzoates 14a,d may serve as lead molecules for the future research regarding the identification of new anticancer agents. These novel compounds were confirmed to be cyclin-dependent kinase 6 and 9 (CDK6 and 9) inhibitors through in silico molecular modeling studies for the mode of action. Graphical abstract: (Figure presented.)
KW - Aminocarbonylation reaction
KW - Anthranilic acid
KW - Cytotoxicity
KW - Molecular docking
KW - Palladium catalyst
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85192818484&origin=inward&txGid=17e20c9c099dbad3c05f604a44ef7910
UR - https://www.mendeley.com/catalogue/94938ec5-e83d-3b00-ba96-1263f9f97859/
U2 - 10.1007/s11696-024-03508-0
DO - 10.1007/s11696-024-03508-0
M3 - Article
VL - 78
SP - 5639
EP - 5656
JO - Chemical Papers
JF - Chemical Papers
SN - 0366-6352
IS - 9
ER -
ID: 60875273